Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Margo A. Smith is active.

Publication


Featured researches published by Margo A. Smith.


Diabetes Care | 2009

A1C Underestimates Glycemia in HIV Infection

Peter S. Kim; Christian Woods; Patrick Georgoff; Dana Crum; Alice Rosenberg; Margo A. Smith; Colleen Hadigan

OBJECTIVE The objective of this study was to determine the relationship between A1C and glycemia in HIV infection. RESEARCH DESIGN AND METHODS We completed a prospective cross-sectional study of 100 HIV-infected adults with type 2 diabetes (77%) or fasting hyperglycemia (23%) with measured glucose, A1C, mean corpuscular volume (MCV), and fructosamine. A total of 200 HIV-uninfected type 2 diabetic subjects matched for key demographic characteristics served as control subjects. RESULTS Relative to the control subjects, A1C underestimated glucose by 29 ± 4 mg/dl in the HIV-infected subjects. Current nucleoside reverse transcriptase inhibitors (NRTIs), higher MCV and hemoglobin, and lower HIV RNA and haptoglobin were associated with greater A1C-glucose discordance. However, only MCV and current NTRI use, in particular abacavir, remained significant predictors in multivariate analyses. Fructosamine more closely reflected glycemia in the HIV-infected subjects. CONCLUSIONS A1C underestimates glycemia in HIV-infected patients and is related to NRTI use. Use of abacavir and increased MCV were key correlates in multivariate analyses. Fructosamine may be more appropriate in this setting.


American Journal of Transplantation | 2002

Primary Cutaneous Fungal Infections in Solid Organ Transplantation: A Case Series

Peter S. Miele; Charles S. Levy; Margo A. Smith; Elizabeth M. Dugan; Richard H. Cooke; Jimmy A. Light; Daniel R. Lucey

Cutaneous fungal infections in solid‐organ transplant patients present in a variety of nonspecific ways, requiring a high index of suspicion to diagnose correctly. In the present series of four transplant recipients, subsequent primary cutaneous fungal infections presented as papules, plaques, ulcers and subcutaneous nodules. Transplantations included one cardiac, two renal and one renal–pancreatic transplant. Fungal infections were limited to the skin; there was no evidence of disseminated disease in any case. The pathogens isolated were Scedosporium apiospermum (Pseudallescheria boydii), Alternaria species, Aspergillus fumigatus, and a coelomycete in the Coniothyrium‐Microsphaeropsis complex of dark molds. Individuals were successfully treated with surgical debridement, antifungal agents, and reduction of immunosuppressive therapy. All patients and allografts survived. Accurate diagnosis, aggressive surgery and appropriate antifungal therapy, combined with close outpatient follow‐up, optimize the likelihood of a cure in a transplant population.


Clinical Immunology | 2010

d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.

Brian O. Porter; G. Laissa Ouedraogo; Jessica N. Hodge; Margo A. Smith; Alice Pau; Gregg Roby; Richard Kwan; Rachel J. Bishop; Catherine Rehm; JoAnn M. Mican; Irini Sereti

Biomarkers could be useful in evaluating immune reconstitution inflammatory syndrome (IRIS). A cohort of 45 HIV-1-infected, antiretroviral treatment (ART)-naive patients with baseline CD4 T cell counts <or=100 cells/microL who were started on ART, suppressed HIV-RNA to <50 copies/mL, and seen every 1-3 months for 1 year were retrospectively evaluated for suspected or confirmed IRIS. d-Dimer, C-reactive protein (CRP), and selected autoantibodies were analyzed at baseline, 1 and 3 months post-ART in cryopreserved plasma. Median differences between cases and controls were compared with Mann-Whitney and Fishers exact tests. Sixteen patients (35.6%) developed IRIS (median of 35 days post-ART initiation): unmasking=8, paradoxical=7, autoimmune=1. Pre-ART d-dimer and CRP were higher in IRIS cases versus controls (d-dimer: 0.89 mg/L versus 0.66 mg /L, p=0.037; CRP: 0.74 mg/L versus 0.39 mg/L, p=0.022), while d-dimer was higher in unmasking cases at IRIS onset (2.04 mg/L versus 0.36 mg /L, p=0.05). These biomarkers may be useful in identifying patients at risk for IRIS.


PLOS ONE | 2011

Increased prevalence of albuminuria in HIV-infected adults with diabetes.

Peter S. Kim; Christian Woods; Lauren Dutcher; Patrick Georgoff; Alice Rosenberg; Jo Ann M. Mican; Jeffrey B. Kopp; Margo A. Smith; Colleen Hadigan

Objective HIV and type 2 diabetes are known risk factors for albuminuria, but no previous reports have characterized albuminuria in HIV-infected patients with diabetes. Research Design and Methods We performed a cross-sectional study including 73 HIV-infected adults with type 2 diabetes, 82 HIV-infected non-diabetics, and 61 diabetic control subjects without HIV. Serum creatinine >1.5 mg/dL was exclusionary. Albuminuria was defined as urinary albumin/creatinine ratio >30 mg/g. Results The prevalence of albuminuria was significantly increased among HIV-infected diabetics (34% vs. 13% of HIV non-diabetic vs. 16% diabetic control, p = 0.005). HIV status and diabetes remained significant predictors of albuminuria after adjusting for age, race, BMI, and blood pressure. Albumin/creatinine ratio correlated significantly with HIV viral load (r = 0.28, p = 0.0005) and HIV-infected subjects with albuminuria had significantly greater cumulative exposure to abacavir (p = 0.01). In an adjusted multivariate regression analysis of HIV-infected subjects, the diagnosis of diabetes (p = 0.003), higher HIV viral load (p = 0.03) and cumulative exposure to abacavir (p = 0.0009) were significant independent predictors of albuminuria. Conclusions HIV and diabetes appear to have additive effects on albuminuria which is also independently associated with increased exposure to abacavir and HIV viral load. Future research on the persistence, progression and management of albuminuria in this unique at-risk population is needed.


International Journal of Gynecological Pathology | 2001

Malakoplakia involving the abdominal wall, urinary bladder, vagina, and vulva: Case report and discussion of malakoplakia-associated bacteria

Palaniandy K. Kogulan; Margo A. Smith; Jeffrey D. Seidman; George Chang; Maria Tsokos; Daniel R. Lucey

A 29-year-old woman presented with a 3-month history of multiple purulent discharging nodules involving her lower abdomen, vulva, and left thigh. Physical examination also disclosed vaginal nodules and a left pelvic mass. Cystoscopy revealed multiple mucosal nodules and a perforation of the left vesical wall that appeared to communicate with the pelvic mass. Biopsies of the vesical and vulvar nodules revealed malakoplakia. Surgery and antibiotic therapy resulted in regression of all the lesions.


Clinical Infectious Diseases | 2009

Domestically Acquired Seoul Virus Causing Hemorrhagic Fever with Renal Syndrome—Maryland, 2008

Christian Woods; Rakhee Palekar; Peter Kim; David Blythe; Olivier de Senarclens; Katherine Feldman; Eileen C. Farnon; Pierre E. Rollin; César G. Albariño; Stuart T. Nichol; Margo A. Smith

Hantaviruses are rodent-borne viruses capable of causing human disease. The Seoul virus is a hantavirus that causes hemorrhagic fever with renal syndrome in East Asia. To our knowledge, we report the first domestically acquired case of hemorrhagic fever with renal syndrome caused by the Seoul virus, confirmed by serology testing, reverse-transcriptase polymerase chain reaction, and nucleotide sequence analysis. The patient presented with myalgias and fever, and developed acute renal failure.


Clinical Infectious Diseases | 2002

Brevibacterium Endocarditis: A First Report

Krishna Dass; Margo A. Smith; Vee J. Gill; Steven A. Goldstein; Daniel R. Lucey

There are few case reports of infections caused by Brevibacterium species, and there have been no previously reported cases of endocarditis caused by any of the 6 known species of Brevibacterium. We report the first case of Brevibacterium endocarditis (caused by Brevibacterium otitidis) in a patient with prosthetic heart valves. The patient responded to 6 weeks of treatment with vancomycin and 2 weeks with gentamicin, and she has been receiving long-term maintenance therapy with oral azithromycin.


American Journal of Nephrology | 2013

Microalbuminuria in HIV Disease

Colleen Hadigan; Elizabeth Edwards; Alice Rosenberg; Julia B. Purdy; Estee Fleischman; Lilian Howard; JoAnn M. Mican; Karmini Sampath; Akinbowale Oyalowo; Antoinette Johnson; Alexandra Adler; Catherine Rehm; Margo A. Smith; Leon Lai; Jeffrey B. Kopp

Background/Aims: Microalbuminuria is a marker for early kidney disease and cardiovascular risk. The purposes of this study were to determine the prevalence of microalbuminuria in an HIV-infected clinic population, to test the predictive value of a single urine albumin/creatinine ratio (ACR) to identify persistent microalbuminuria and to examine covariates of microalbuminuria. Methods: We conducted a prospective cohort study of HIV-infected subjects (n = 182) without proteinuria (urine protein/creatinine ratio ≥0.5 g/g), elevated serum creatinine, diabetes, or chronic inflammatory conditions. Subjects completed three research visits within 9 months. Microalbuminuria was defined as the geometric mean ACR of 25-355 mg/g for females and 17-250 mg/g for males. Results: The prevalence of microalbuminuria was 14%. The negative predictive value of a single urine ACR determination was 98%, whereas the positive predictive value was only 74%. Microalbuminuria was similar among Black (15%) and non-Black (14%) subjects (p = 0.8). Subjects with microalbuminuria were more likely to have hypertension (p = 0.02) and metabolic syndrome (p = 0.03). While duration of HIV infection and the level of HIV viremia were similar between groups, those with microalbuminuria were more likely to have a CD4 count <200 cells/μl (p = 0.0003). In a multivariate logistic regression analysis, the only significant independent predictors of microalbuminuria were low CD4 count (p = 0.018) and current ritonavir exposure (p = 0.04). Conclusion: The prevalence of microalbuminuria in an HIV-infected clinic population was similar to earlier reports, and was associated with hypertension and impaired immune function. A single normal ACR determination effectively excludes microalbuminuria, whereas an elevated ACR requires confirmation.


Infectious Diseases in Clinical Practice | 2002

Twenty-six cases of malaria at the washington hospital center: A spectrum of clinical complications and a therapeutic algorithm

Nhat M. Doan; Kitonga Kiminyo; Marissa B. Wilck; Mary Ann Alexander; Margo A. Smith; Daniel R. Lucey

Malaria is the most common identified cause of fever in travelers returning to the United States from an area in which malaria is endemic. We reviewed 26 cases of malaria seen at the Washington Hospital Center between 1996 and 2000. Only three patients reported taking appropriate malaria prophylaxis. Twenty-five patients presented within 2 weeks of returning to the United States. Notable presentations included parasitemia (27%) and multiorgan failure requiring exchange transfusion (one patient), nausea and vomiting (three patients, including one who had severe diarrhea), and syncope (three patients). Complications included acute renal failure, respiratory failure requiring intubation, pulmonary edema, and QT prolongation due to quinidine (one patient each). Common laboratory findings included anemia (hematocrit, <42% for men and <37% for women), decreased total white blood cell count (<4.8 K/μl), and thrombocytopenia (platelets, <150 K/μl). All patients fully recovered after appropriate therapy. In conclusion, (1) because fever was a universal finding, malaria should always be suspected and blood smears should be examined if a patient with a fever has been traveling in an area of endemicity; (2) other manifestations included gastrointestinal symptoms and syncope, anemia, low-normal white blood cell count, and thrombocytopenia; (3) appropriate malaria prophylaxis was typically neglected; and (4) malaria can be fatal but is curable if diagnosed and treated correctly. The clinical algorithm used to manage malaria at the Washington Hospital Center is presented.


Infectious Diseases in Clinical Practice | 2006

Use of cardiovascular magnetic resonance imaging in acute rheumatic fever

Rebecca Shaffer; Anthon Fuisz; Kenneth Lee; Margo A. Smith

Abstract: We report a case of acute rheumatic fever in a 46-year-old man diagnosed with the assistance of contrast cardiovascular magnetic resonance imaging. This case demonstrates the use of contrast cardiovascular magnetic resonance imaging as a noninvasive method for detecting carditis and contributing to the diagnosis and management of acute rheumatic fever.

Collaboration


Dive into the Margo A. Smith's collaboration.

Top Co-Authors

Avatar

Daniel R. Lucey

MedStar Washington Hospital Center

View shared research outputs
Top Co-Authors

Avatar

Charles S. Levy

MedStar Washington Hospital Center

View shared research outputs
Top Co-Authors

Avatar

Catherine Rehm

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

JoAnn M. Mican

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Alice Pau

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Alice Rosenberg

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Brian O. Porter

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Christian Woods

MedStar Washington Hospital Center

View shared research outputs
Top Co-Authors

Avatar

Colleen Hadigan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

G. Laissa Ouedraogo

Science Applications International Corporation

View shared research outputs
Researchain Logo
Decentralizing Knowledge